Optimapharm Acquires Czech MKS Research

Article

Applied Clinical Trials

Following the global trend of consolidating market positions of clinical research organizations (CROs), Optimapharm acquired the Czech CRO company MKS Research. With this acquirement, Optimapharm hopes to strengthen its clientele across the pharmaceutical and biotech industries all while building revenue.

Read the full release here.

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.